Question 1

Who are the top researchers at Instituto Hispalense de Pediatria?

Accepted Answer

Ranked on the quality score, Ignacio Salamanca de la Cueva, Tiago Jeronimo Dos Santos and Alfonso Carmona lead among researchers whose main affiliation is Instituto Hispalense de Pediatria.

Question 2

What are the most cited papers from Instituto Hispalense de Pediatria?

Accepted Answer

The most cited paper from Instituto Hispalense de Pediatria is "Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing" (María de Lourdes Moreno, Ángel Cebolla, Alba Muñoz-Suano et al., 2015), with 324 citations. Next come "Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients" (210) and "ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery" (151).

Question 3

Which research topics does Instituto Hispalense de Pediatria publish most on?

Accepted Answer

By volume in 2022-now: Bacterial Infections and Vaccines, Pneumonia and Respiratory Infections, Influenza Virus Research Studies and Marine animal studies overview.

Question 4

Which keywords describe research at Instituto Hispalense de Pediatria?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Health Promotion, Nutrition, Risk Factors, Mental Health, Vaccine and Physical Activity.

Question 5

Which fields of science does Instituto Hispalense de Pediatria work in?

Accepted Answer

In all years, 58% of research at Instituto Hispalense de Pediatria is in Health Sciences, 21% in Social Sciences. Its largest fields are Medicine (45%), Social Sciences (11%), Health Professions (9%). It does 2.1× the world's share of Health Sciences.

Question 6

Is Instituto Hispalense de Pediatria's research output growing?

Accepted Answer

Output in 2022-2025 was 22% higher than in 2018-2021.